Literature DB >> 6541807

Separation of morphine analgesia from physical dependence.

G S Ling, J M MacLeod, S Lee, S H Lockhart, G W Pasternak.   

Abstract

Intravenous infusion of morphine sulfate in rats for 24 hours produced marked opioid dependence, manifested by a series of well-documented signs appearing after injection of the opiate antagonist naloxone. Treatment of rats with naloxonazine significantly reduced the analgesia associated with the morphine infusions for more than 24 hours. Furthermore, 14 of 16 withdrawal signs observed in naloxonazine-treated rats were virtually identical to those in rats that received morphine alone. These results raise the possibility that different receptor mechanisms mediate morphine analgesia and many of the withdrawal signs associated with morphine dependence.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6541807     DOI: 10.1126/science.6541807

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  27 in total

1.  Synthesis and evaluation of aryl-naloxamide opiate analgesics targeting truncated exon 11-associated μ opioid receptor (MOR-1) splice variants.

Authors:  Susruta Majumdar; Joan Subrath; Valerie Le Rouzic; Lisa Polikar; Maxim Burgman; Kuni Nagakura; Julie Ocampo; Nathan Haselton; Anna R Pasternak; Steven Grinnell; Ying-Xian Pan; Gavril W Pasternak
Journal:  J Med Chem       Date:  2012-07-16       Impact factor: 7.446

2.  Splice variation of the mu-opioid receptor and its effect on the action of opioids.

Authors:  Sophy K Gretton; Joanne Droney
Journal:  Br J Pain       Date:  2014-11

Review 3.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

4.  The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic pain.

Authors:  Diana Vivian Atigari; Kelly Frances Paton; Rajendra Uprety; András Váradi; Amy Frances Alder; Brittany Scouller; John H Miller; Susruta Majumdar; Bronwyn Maree Kivell
Journal:  Neuropharmacology       Date:  2020-12-28       Impact factor: 5.250

5.  Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine.

Authors:  Jin Xu; Zhigang Lu; Ankita Narayan; Valerie P Le Rouzic; Mingming Xu; Amanda Hunkele; Taylor G Brown; William F Hoefer; Grace C Rossi; Richard C Rice; Arlene Martínez-Rivera; Anjali M Rajadhyaksha; Luca Cartegni; Daniel L Bassoni; Gavril W Pasternak; Ying-Xian Pan
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

6.  A "tail" of opioid receptor variants.

Authors:  Stephanie Puig; Howard B Gutstein
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

Review 7.  Opiate pharmacology and relief of pain.

Authors:  Gavril W Pasternak
Journal:  J Clin Oncol       Date:  2014-05-05       Impact factor: 44.544

8.  Genetic dissociation of morphine analgesia from hyperalgesia in mice.

Authors:  Gina F Marrone; Valerie Le Rouzic; Andras Varadi; Jin Xu; Anjali M Rajadhyaksha; Susruta Majumdar; Ying-Xian Pan; Gavril W Pasternak
Journal:  Psychopharmacology (Berl)       Date:  2017-03-25       Impact factor: 4.530

9.  Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene.

Authors:  Jin Xu; Mingming Xu; Yasmin L Hurd; Gavril W Pasternak; Ying-Xian Pan
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

10.  Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine.

Authors:  L Singh; R J Oles; M J Field; P Atwal; G N Woodruff; J C Hunter
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.